nodes	percent_of_prediction	percent_of_DWPC	metapath
Leflunomide—ABCG2—Nelfinavir—acquired immunodeficiency syndrome	0.0587	0.0875	CbGbCtD
Leflunomide—ABCG2—Ritonavir—acquired immunodeficiency syndrome	0.053	0.0791	CbGbCtD
Leflunomide—ABCG2—Saquinavir—acquired immunodeficiency syndrome	0.053	0.0791	CbGbCtD
Leflunomide—ABCG2—Zidovudine—acquired immunodeficiency syndrome	0.0509	0.0759	CbGbCtD
Leflunomide—ABCG2—Lamivudine—acquired immunodeficiency syndrome	0.0393	0.0587	CbGbCtD
Leflunomide—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.0339	0.0506	CbGbCtD
Leflunomide—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0319	0.0476	CbGbCtD
Leflunomide—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0319	0.0476	CbGbCtD
Leflunomide—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0306	0.0456	CbGbCtD
Leflunomide—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.0289	0.0431	CbGbCtD
Leflunomide—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0288	0.0429	CbGbCtD
Leflunomide—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0288	0.0429	CbGbCtD
Leflunomide—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.026	0.0388	CbGbCtD
Leflunomide—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.026	0.0388	CbGbCtD
Leflunomide—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0242	0.0361	CbGbCtD
Leflunomide—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.0224	0.0335	CbGbCtD
Leflunomide—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.0219	0.0326	CbGbCtD
Leflunomide—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.0218	0.0325	CbGbCtD
Leflunomide—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.0197	0.0294	CbGbCtD
Leflunomide—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.0197	0.0294	CbGbCtD
Leflunomide—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.0189	0.0282	CbGbCtD
Leflunomide—PTK2B—blood plasma—acquired immunodeficiency syndrome	0.00505	0.0885	CbGeAlD
Leflunomide—DHODH—skin of body—acquired immunodeficiency syndrome	0.00383	0.0672	CbGeAlD
Leflunomide—DHODH—lymphoid tissue—acquired immunodeficiency syndrome	0.0031	0.0544	CbGeAlD
Leflunomide—DHODH—blood—acquired immunodeficiency syndrome	0.00292	0.0512	CbGeAlD
Leflunomide—DHODH—lung—acquired immunodeficiency syndrome	0.00256	0.0449	CbGeAlD
Leflunomide—PTK2B—lymphoid tissue—acquired immunodeficiency syndrome	0.00197	0.0345	CbGeAlD
Leflunomide—PTK2B—digestive system—acquired immunodeficiency syndrome	0.00194	0.034	CbGeAlD
Leflunomide—PTK2B—blood—acquired immunodeficiency syndrome	0.00185	0.0324	CbGeAlD
Leflunomide—DHODH—brain—acquired immunodeficiency syndrome	0.00181	0.0318	CbGeAlD
Leflunomide—PTK2B—bone marrow—acquired immunodeficiency syndrome	0.00179	0.0314	CbGeAlD
Leflunomide—DHODH—lymph node—acquired immunodeficiency syndrome	0.00175	0.0307	CbGeAlD
Leflunomide—PTK2B—vagina—acquired immunodeficiency syndrome	0.00172	0.0301	CbGeAlD
Leflunomide—PTK2B—lung—acquired immunodeficiency syndrome	0.00162	0.0284	CbGeAlD
Leflunomide—AHR—digestive system—acquired immunodeficiency syndrome	0.0016	0.028	CbGeAlD
Leflunomide—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.00155	0.0272	CbGeAlD
Leflunomide—AHR—blood—acquired immunodeficiency syndrome	0.00152	0.0267	CbGeAlD
Leflunomide—PTK2B—nervous system—acquired immunodeficiency syndrome	0.0015	0.0263	CbGeAlD
Leflunomide—AHR—bone marrow—acquired immunodeficiency syndrome	0.00147	0.0258	CbGeAlD
Leflunomide—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.00147	0.0258	CbGeAlD
Leflunomide—AHR—spinal cord—acquired immunodeficiency syndrome	0.00147	0.0257	CbGeAlD
Leflunomide—PTK2B—central nervous system—acquired immunodeficiency syndrome	0.00145	0.0253	CbGeAlD
Leflunomide—AHR—vagina—acquired immunodeficiency syndrome	0.00141	0.0247	CbGeAlD
Leflunomide—AHR—lung—acquired immunodeficiency syndrome	0.00133	0.0234	CbGeAlD
Leflunomide—PTK2B—brain—acquired immunodeficiency syndrome	0.00115	0.0201	CbGeAlD
Leflunomide—PTK2B—lymph node—acquired immunodeficiency syndrome	0.00111	0.0194	CbGeAlD
Leflunomide—AHR—brain—acquired immunodeficiency syndrome	0.000944	0.0165	CbGeAlD
Leflunomide—AHR—lymph node—acquired immunodeficiency syndrome	0.000912	0.016	CbGeAlD
Leflunomide—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.000596	0.0104	CbGeAlD
Leflunomide—ABCG2—blood—acquired immunodeficiency syndrome	0.00059	0.0103	CbGeAlD
Leflunomide—ABCG2—bone marrow—acquired immunodeficiency syndrome	0.000571	0.01	CbGeAlD
Leflunomide—ABCG2—spinal cord—acquired immunodeficiency syndrome	0.000569	0.00996	CbGeAlD
Leflunomide—CYP1A2—blood—acquired immunodeficiency syndrome	0.000568	0.00995	CbGeAlD
Leflunomide—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000566	0.00991	CbGeAlD
Leflunomide—ABCG2—vagina—acquired immunodeficiency syndrome	0.000547	0.00958	CbGeAlD
Leflunomide—CYP2C9—blood—acquired immunodeficiency syndrome	0.000539	0.00944	CbGeAlD
Leflunomide—ABCG2—lung—acquired immunodeficiency syndrome	0.000517	0.00906	CbGeAlD
Leflunomide—CYP1A2—lung—acquired immunodeficiency syndrome	0.000498	0.00872	CbGeAlD
Leflunomide—ABCG2—brain—acquired immunodeficiency syndrome	0.000366	0.00641	CbGeAlD
Leflunomide—ABCG2—lymph node—acquired immunodeficiency syndrome	0.000354	0.0062	CbGeAlD
Leflunomide—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000106	0.000389	CcSEcCtD
Leflunomide—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000106	0.000388	CcSEcCtD
Leflunomide—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000106	0.000388	CcSEcCtD
Leflunomide—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000106	0.000387	CcSEcCtD
Leflunomide—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000105	0.000387	CcSEcCtD
Leflunomide—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000105	0.000386	CcSEcCtD
Leflunomide—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000105	0.000386	CcSEcCtD
Leflunomide—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000105	0.000386	CcSEcCtD
Leflunomide—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000105	0.000385	CcSEcCtD
Leflunomide—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000105	0.000385	CcSEcCtD
Leflunomide—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000105	0.000384	CcSEcCtD
Leflunomide—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000105	0.000384	CcSEcCtD
Leflunomide—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000105	0.000384	CcSEcCtD
Leflunomide—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000105	0.000384	CcSEcCtD
Leflunomide—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000105	0.000384	CcSEcCtD
Leflunomide—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000104	0.000382	CcSEcCtD
Leflunomide—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000104	0.000382	CcSEcCtD
Leflunomide—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000104	0.000382	CcSEcCtD
Leflunomide—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000104	0.000381	CcSEcCtD
Leflunomide—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000104	0.00038	CcSEcCtD
Leflunomide—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000103	0.000379	CcSEcCtD
Leflunomide—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000103	0.000379	CcSEcCtD
Leflunomide—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000103	0.000379	CcSEcCtD
Leflunomide—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000103	0.000379	CcSEcCtD
Leflunomide—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000103	0.000379	CcSEcCtD
Leflunomide—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000103	0.000378	CcSEcCtD
Leflunomide—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000103	0.000378	CcSEcCtD
Leflunomide—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000103	0.000376	CcSEcCtD
Leflunomide—Pain—Indinavir—acquired immunodeficiency syndrome	0.000103	0.000376	CcSEcCtD
Leflunomide—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000103	0.000376	CcSEcCtD
Leflunomide—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000102	0.000376	CcSEcCtD
Leflunomide—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000102	0.000375	CcSEcCtD
Leflunomide—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000102	0.000374	CcSEcCtD
Leflunomide—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000102	0.000374	CcSEcCtD
Leflunomide—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000102	0.000374	CcSEcCtD
Leflunomide—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000102	0.000374	CcSEcCtD
Leflunomide—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000102	0.000373	CcSEcCtD
Leflunomide—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000102	0.000373	CcSEcCtD
Leflunomide—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000102	0.000372	CcSEcCtD
Leflunomide—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000102	0.000372	CcSEcCtD
Leflunomide—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000101	0.000372	CcSEcCtD
Leflunomide—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000101	0.000372	CcSEcCtD
Leflunomide—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000101	0.000371	CcSEcCtD
Leflunomide—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000101	0.00037	CcSEcCtD
Leflunomide—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000101	0.000369	CcSEcCtD
Leflunomide—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000101	0.000369	CcSEcCtD
Leflunomide—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000101	0.000369	CcSEcCtD
Leflunomide—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.0001	0.000368	CcSEcCtD
Leflunomide—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.0001	0.000367	CcSEcCtD
Leflunomide—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.0001	0.000367	CcSEcCtD
Leflunomide—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	9.98e-05	0.000366	CcSEcCtD
Leflunomide—Discomfort—Saquinavir—acquired immunodeficiency syndrome	9.95e-05	0.000365	CcSEcCtD
Leflunomide—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	9.89e-05	0.000363	CcSEcCtD
Leflunomide—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	9.88e-05	0.000362	CcSEcCtD
Leflunomide—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	9.85e-05	0.000361	CcSEcCtD
Leflunomide—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	9.85e-05	0.000361	CcSEcCtD
Leflunomide—Cough—Lamivudine—acquired immunodeficiency syndrome	9.85e-05	0.000361	CcSEcCtD
Leflunomide—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	9.85e-05	0.000361	CcSEcCtD
Leflunomide—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	9.84e-05	0.000361	CcSEcCtD
Leflunomide—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	9.82e-05	0.00036	CcSEcCtD
Leflunomide—Dizziness—Stavudine—acquired immunodeficiency syndrome	9.82e-05	0.00036	CcSEcCtD
Leflunomide—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	9.81e-05	0.00036	CcSEcCtD
Leflunomide—Insomnia—Delavirdine—acquired immunodeficiency syndrome	9.81e-05	0.00036	CcSEcCtD
Leflunomide—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	9.79e-05	0.000359	CcSEcCtD
Leflunomide—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	9.79e-05	0.000359	CcSEcCtD
Leflunomide—Vomiting—Nevirapine—acquired immunodeficiency syndrome	9.77e-05	0.000358	CcSEcCtD
Leflunomide—Fatigue—Efavirenz—acquired immunodeficiency syndrome	9.77e-05	0.000358	CcSEcCtD
Leflunomide—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	9.74e-05	0.000357	CcSEcCtD
Leflunomide—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	9.74e-05	0.000357	CcSEcCtD
Leflunomide—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	9.7e-05	0.000356	CcSEcCtD
Leflunomide—Pain—Efavirenz—acquired immunodeficiency syndrome	9.69e-05	0.000355	CcSEcCtD
Leflunomide—Constipation—Efavirenz—acquired immunodeficiency syndrome	9.69e-05	0.000355	CcSEcCtD
Leflunomide—Rash—Nevirapine—acquired immunodeficiency syndrome	9.69e-05	0.000355	CcSEcCtD
Leflunomide—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	9.68e-05	0.000355	CcSEcCtD
Leflunomide—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	9.67e-05	0.000355	CcSEcCtD
Leflunomide—Dizziness—Abacavir—acquired immunodeficiency syndrome	9.67e-05	0.000355	CcSEcCtD
Leflunomide—Headache—Nevirapine—acquired immunodeficiency syndrome	9.63e-05	0.000353	CcSEcCtD
Leflunomide—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	9.61e-05	0.000352	CcSEcCtD
Leflunomide—Myalgia—Lamivudine—acquired immunodeficiency syndrome	9.61e-05	0.000352	CcSEcCtD
Leflunomide—Chest pain—Lamivudine—acquired immunodeficiency syndrome	9.61e-05	0.000352	CcSEcCtD
Leflunomide—Infection—Saquinavir—acquired immunodeficiency syndrome	9.59e-05	0.000352	CcSEcCtD
Leflunomide—Anxiety—Lamivudine—acquired immunodeficiency syndrome	9.57e-05	0.000351	CcSEcCtD
Leflunomide—Anorexia—Ritonavir—acquired immunodeficiency syndrome	9.56e-05	0.000351	CcSEcCtD
Leflunomide—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	9.55e-05	0.00035	CcSEcCtD
Leflunomide—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	9.54e-05	0.00035	CcSEcCtD
Leflunomide—Urticaria—Indinavir—acquired immunodeficiency syndrome	9.53e-05	0.000349	CcSEcCtD
Leflunomide—Discomfort—Lamivudine—acquired immunodeficiency syndrome	9.49e-05	0.000348	CcSEcCtD
Leflunomide—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	9.48e-05	0.000348	CcSEcCtD
Leflunomide—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	9.48e-05	0.000348	CcSEcCtD
Leflunomide—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	9.47e-05	0.000347	CcSEcCtD
Leflunomide—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	9.47e-05	0.000347	CcSEcCtD
Leflunomide—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	9.45e-05	0.000347	CcSEcCtD
Leflunomide—Vomiting—Stavudine—acquired immunodeficiency syndrome	9.44e-05	0.000346	CcSEcCtD
Leflunomide—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	9.43e-05	0.000346	CcSEcCtD
Leflunomide—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	9.4e-05	0.000345	CcSEcCtD
Leflunomide—Rash—Nelfinavir—acquired immunodeficiency syndrome	9.39e-05	0.000344	CcSEcCtD
Leflunomide—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	9.38e-05	0.000344	CcSEcCtD
Leflunomide—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	9.38e-05	0.000344	CcSEcCtD
Leflunomide—Hypotension—Ritonavir—acquired immunodeficiency syndrome	9.37e-05	0.000344	CcSEcCtD
Leflunomide—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	9.36e-05	0.000343	CcSEcCtD
Leflunomide—Rash—Stavudine—acquired immunodeficiency syndrome	9.36e-05	0.000343	CcSEcCtD
Leflunomide—Fatigue—Delavirdine—acquired immunodeficiency syndrome	9.35e-05	0.000343	CcSEcCtD
Leflunomide—Dermatitis—Stavudine—acquired immunodeficiency syndrome	9.35e-05	0.000343	CcSEcCtD
Leflunomide—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	9.34e-05	0.000343	CcSEcCtD
Leflunomide—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	9.33e-05	0.000342	CcSEcCtD
Leflunomide—Headache—Nelfinavir—acquired immunodeficiency syndrome	9.33e-05	0.000342	CcSEcCtD
Leflunomide—Headache—Stavudine—acquired immunodeficiency syndrome	9.3e-05	0.000341	CcSEcCtD
Leflunomide—Vomiting—Abacavir—acquired immunodeficiency syndrome	9.3e-05	0.000341	CcSEcCtD
Leflunomide—Pain—Delavirdine—acquired immunodeficiency syndrome	9.27e-05	0.00034	CcSEcCtD
Leflunomide—Constipation—Delavirdine—acquired immunodeficiency syndrome	9.27e-05	0.00034	CcSEcCtD
Leflunomide—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	9.27e-05	0.00034	CcSEcCtD
Leflunomide—Asthenia—Zidovudine—acquired immunodeficiency syndrome	9.26e-05	0.000339	CcSEcCtD
Leflunomide—Rash—Abacavir—acquired immunodeficiency syndrome	9.22e-05	0.000338	CcSEcCtD
Leflunomide—Dermatitis—Abacavir—acquired immunodeficiency syndrome	9.21e-05	0.000338	CcSEcCtD
Leflunomide—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	9.21e-05	0.000338	CcSEcCtD
Leflunomide—Anorexia—Saquinavir—acquired immunodeficiency syndrome	9.2e-05	0.000337	CcSEcCtD
Leflunomide—Headache—Abacavir—acquired immunodeficiency syndrome	9.16e-05	0.000336	CcSEcCtD
Leflunomide—Infection—Lamivudine—acquired immunodeficiency syndrome	9.15e-05	0.000335	CcSEcCtD
Leflunomide—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	9.14e-05	0.000335	CcSEcCtD
Leflunomide—Nausea—Nevirapine—acquired immunodeficiency syndrome	9.13e-05	0.000335	CcSEcCtD
Leflunomide—Pruritus—Zidovudine—acquired immunodeficiency syndrome	9.13e-05	0.000335	CcSEcCtD
Leflunomide—Insomnia—Ritonavir—acquired immunodeficiency syndrome	9.07e-05	0.000333	CcSEcCtD
Leflunomide—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	9.03e-05	0.000331	CcSEcCtD
Leflunomide—Hypotension—Saquinavir—acquired immunodeficiency syndrome	9.02e-05	0.000331	CcSEcCtD
Leflunomide—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	9.02e-05	0.000331	CcSEcCtD
Leflunomide—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	9.01e-05	0.00033	CcSEcCtD
Leflunomide—Urticaria—Efavirenz—acquired immunodeficiency syndrome	9.01e-05	0.00033	CcSEcCtD
Leflunomide—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	8.96e-05	0.000329	CcSEcCtD
Leflunomide—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	8.96e-05	0.000329	CcSEcCtD
Leflunomide—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	8.95e-05	0.000328	CcSEcCtD
Leflunomide—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	8.94e-05	0.000328	CcSEcCtD
Leflunomide—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	8.94e-05	0.000328	CcSEcCtD
Leflunomide—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	8.9e-05	0.000326	CcSEcCtD
Leflunomide—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	8.87e-05	0.000325	CcSEcCtD
Leflunomide—Nausea—Nelfinavir—acquired immunodeficiency syndrome	8.84e-05	0.000324	CcSEcCtD
Leflunomide—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	8.84e-05	0.000324	CcSEcCtD
Leflunomide—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	8.83e-05	0.000324	CcSEcCtD
Leflunomide—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	8.83e-05	0.000324	CcSEcCtD
Leflunomide—Nausea—Stavudine—acquired immunodeficiency syndrome	8.82e-05	0.000323	CcSEcCtD
Leflunomide—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	8.8e-05	0.000322	CcSEcCtD
Leflunomide—Anorexia—Lamivudine—acquired immunodeficiency syndrome	8.78e-05	0.000322	CcSEcCtD
Leflunomide—Insomnia—Saquinavir—acquired immunodeficiency syndrome	8.73e-05	0.00032	CcSEcCtD
Leflunomide—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	8.72e-05	0.00032	CcSEcCtD
Leflunomide—Nausea—Abacavir—acquired immunodeficiency syndrome	8.69e-05	0.000318	CcSEcCtD
Leflunomide—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	8.67e-05	0.000318	CcSEcCtD
Leflunomide—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	8.66e-05	0.000318	CcSEcCtD
Leflunomide—Fatigue—Ritonavir—acquired immunodeficiency syndrome	8.65e-05	0.000317	CcSEcCtD
Leflunomide—Urticaria—Delavirdine—acquired immunodeficiency syndrome	8.62e-05	0.000316	CcSEcCtD
Leflunomide—Asthenia—Indinavir—acquired immunodeficiency syndrome	8.61e-05	0.000316	CcSEcCtD
Leflunomide—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	8.61e-05	0.000316	CcSEcCtD
Leflunomide—Hypotension—Lamivudine—acquired immunodeficiency syndrome	8.61e-05	0.000316	CcSEcCtD
Leflunomide—Constipation—Ritonavir—acquired immunodeficiency syndrome	8.58e-05	0.000314	CcSEcCtD
Leflunomide—Pain—Ritonavir—acquired immunodeficiency syndrome	8.58e-05	0.000314	CcSEcCtD
Leflunomide—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	8.57e-05	0.000314	CcSEcCtD
Leflunomide—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	8.57e-05	0.000314	CcSEcCtD
Leflunomide—Dizziness—Zidovudine—acquired immunodeficiency syndrome	8.53e-05	0.000313	CcSEcCtD
Leflunomide—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	8.5e-05	0.000312	CcSEcCtD
Leflunomide—Pruritus—Indinavir—acquired immunodeficiency syndrome	8.49e-05	0.000311	CcSEcCtD
Leflunomide—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	8.39e-05	0.000308	CcSEcCtD
Leflunomide—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	8.39e-05	0.000308	CcSEcCtD
Leflunomide—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	8.35e-05	0.000306	CcSEcCtD
Leflunomide—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	8.33e-05	0.000306	CcSEcCtD
Leflunomide—Insomnia—Lamivudine—acquired immunodeficiency syndrome	8.33e-05	0.000305	CcSEcCtD
Leflunomide—Fatigue—Saquinavir—acquired immunodeficiency syndrome	8.32e-05	0.000305	CcSEcCtD
Leflunomide—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	8.27e-05	0.000303	CcSEcCtD
Leflunomide—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	8.27e-05	0.000303	CcSEcCtD
Leflunomide—Constipation—Saquinavir—acquired immunodeficiency syndrome	8.26e-05	0.000303	CcSEcCtD
Leflunomide—Pain—Saquinavir—acquired immunodeficiency syndrome	8.26e-05	0.000303	CcSEcCtD
Leflunomide—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	8.21e-05	0.000301	CcSEcCtD
Leflunomide—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	8.21e-05	0.000301	CcSEcCtD
Leflunomide—Vomiting—Zidovudine—acquired immunodeficiency syndrome	8.2e-05	0.000301	CcSEcCtD
Leflunomide—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	8.2e-05	0.000301	CcSEcCtD
Leflunomide—Rash—Zidovudine—acquired immunodeficiency syndrome	8.13e-05	0.000298	CcSEcCtD
Leflunomide—Asthenia—Efavirenz—acquired immunodeficiency syndrome	8.13e-05	0.000298	CcSEcCtD
Leflunomide—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	8.13e-05	0.000298	CcSEcCtD
Leflunomide—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	8.11e-05	0.000297	CcSEcCtD
Leflunomide—Headache—Zidovudine—acquired immunodeficiency syndrome	8.08e-05	0.000296	CcSEcCtD
Leflunomide—Pruritus—Efavirenz—acquired immunodeficiency syndrome	8.02e-05	0.000294	CcSEcCtD
Leflunomide—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	8.01e-05	0.000294	CcSEcCtD
Leflunomide—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	7.99e-05	0.000293	CcSEcCtD
Leflunomide—Urticaria—Ritonavir—acquired immunodeficiency syndrome	7.97e-05	0.000292	CcSEcCtD
Leflunomide—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	7.96e-05	0.000292	CcSEcCtD
Leflunomide—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	7.95e-05	0.000292	CcSEcCtD
Leflunomide—Fatigue—Lamivudine—acquired immunodeficiency syndrome	7.94e-05	0.000291	CcSEcCtD
Leflunomide—Dizziness—Indinavir—acquired immunodeficiency syndrome	7.93e-05	0.000291	CcSEcCtD
Leflunomide—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	7.93e-05	0.000291	CcSEcCtD
Leflunomide—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	7.93e-05	0.000291	CcSEcCtD
Leflunomide—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	7.89e-05	0.000289	CcSEcCtD
Leflunomide—Pain—Lamivudine—acquired immunodeficiency syndrome	7.88e-05	0.000289	CcSEcCtD
Leflunomide—Constipation—Lamivudine—acquired immunodeficiency syndrome	7.88e-05	0.000289	CcSEcCtD
Leflunomide—Asthenia—Delavirdine—acquired immunodeficiency syndrome	7.78e-05	0.000285	CcSEcCtD
Leflunomide—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	7.76e-05	0.000284	CcSEcCtD
Leflunomide—Pruritus—Delavirdine—acquired immunodeficiency syndrome	7.67e-05	0.000281	CcSEcCtD
Leflunomide—Urticaria—Saquinavir—acquired immunodeficiency syndrome	7.67e-05	0.000281	CcSEcCtD
Leflunomide—Nausea—Zidovudine—acquired immunodeficiency syndrome	7.66e-05	0.000281	CcSEcCtD
Leflunomide—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	7.63e-05	0.00028	CcSEcCtD
Leflunomide—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	7.63e-05	0.00028	CcSEcCtD
Leflunomide—Vomiting—Indinavir—acquired immunodeficiency syndrome	7.63e-05	0.00028	CcSEcCtD
Leflunomide—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	7.59e-05	0.000278	CcSEcCtD
Leflunomide—Rash—Indinavir—acquired immunodeficiency syndrome	7.56e-05	0.000277	CcSEcCtD
Leflunomide—Dermatitis—Indinavir—acquired immunodeficiency syndrome	7.56e-05	0.000277	CcSEcCtD
Leflunomide—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	7.53e-05	0.000276	CcSEcCtD
Leflunomide—Headache—Indinavir—acquired immunodeficiency syndrome	7.52e-05	0.000276	CcSEcCtD
Leflunomide—Dizziness—Efavirenz—acquired immunodeficiency syndrome	7.5e-05	0.000275	CcSEcCtD
Leflunomide—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	7.42e-05	0.000272	CcSEcCtD
Leflunomide—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	7.39e-05	0.000271	CcSEcCtD
Leflunomide—Urticaria—Lamivudine—acquired immunodeficiency syndrome	7.32e-05	0.000268	CcSEcCtD
Leflunomide—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	7.28e-05	0.000267	CcSEcCtD
Leflunomide—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	7.28e-05	0.000267	CcSEcCtD
Leflunomide—Vomiting—Efavirenz—acquired immunodeficiency syndrome	7.21e-05	0.000264	CcSEcCtD
Leflunomide—Asthenia—Ritonavir—acquired immunodeficiency syndrome	7.2e-05	0.000264	CcSEcCtD
Leflunomide—Dizziness—Delavirdine—acquired immunodeficiency syndrome	7.17e-05	0.000263	CcSEcCtD
Leflunomide—Rash—Efavirenz—acquired immunodeficiency syndrome	7.15e-05	0.000262	CcSEcCtD
Leflunomide—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	7.14e-05	0.000262	CcSEcCtD
Leflunomide—Nausea—Indinavir—acquired immunodeficiency syndrome	7.13e-05	0.000261	CcSEcCtD
Leflunomide—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	7.11e-05	0.000261	CcSEcCtD
Leflunomide—Headache—Efavirenz—acquired immunodeficiency syndrome	7.1e-05	0.00026	CcSEcCtD
Leflunomide—Pruritus—Ritonavir—acquired immunodeficiency syndrome	7.1e-05	0.00026	CcSEcCtD
Leflunomide—Asthenia—Saquinavir—acquired immunodeficiency syndrome	6.93e-05	0.000254	CcSEcCtD
Leflunomide—Vomiting—Delavirdine—acquired immunodeficiency syndrome	6.9e-05	0.000253	CcSEcCtD
Leflunomide—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	6.86e-05	0.000252	CcSEcCtD
Leflunomide—Rash—Delavirdine—acquired immunodeficiency syndrome	6.84e-05	0.000251	CcSEcCtD
Leflunomide—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	6.83e-05	0.000251	CcSEcCtD
Leflunomide—Pruritus—Saquinavir—acquired immunodeficiency syndrome	6.83e-05	0.00025	CcSEcCtD
Leflunomide—Headache—Delavirdine—acquired immunodeficiency syndrome	6.79e-05	0.000249	CcSEcCtD
Leflunomide—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	6.79e-05	0.000249	CcSEcCtD
Leflunomide—Nausea—Efavirenz—acquired immunodeficiency syndrome	6.73e-05	0.000247	CcSEcCtD
Leflunomide—Dizziness—Ritonavir—acquired immunodeficiency syndrome	6.63e-05	0.000243	CcSEcCtD
Leflunomide—Asthenia—Lamivudine—acquired immunodeficiency syndrome	6.61e-05	0.000242	CcSEcCtD
Leflunomide—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	6.61e-05	0.000242	CcSEcCtD
Leflunomide—Pruritus—Lamivudine—acquired immunodeficiency syndrome	6.52e-05	0.000239	CcSEcCtD
Leflunomide—Nausea—Delavirdine—acquired immunodeficiency syndrome	6.44e-05	0.000236	CcSEcCtD
Leflunomide—Dizziness—Saquinavir—acquired immunodeficiency syndrome	6.38e-05	0.000234	CcSEcCtD
Leflunomide—Vomiting—Ritonavir—acquired immunodeficiency syndrome	6.38e-05	0.000234	CcSEcCtD
Leflunomide—Rash—Ritonavir—acquired immunodeficiency syndrome	6.32e-05	0.000232	CcSEcCtD
Leflunomide—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	6.32e-05	0.000232	CcSEcCtD
Leflunomide—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	6.3e-05	0.000231	CcSEcCtD
Leflunomide—Headache—Ritonavir—acquired immunodeficiency syndrome	6.28e-05	0.00023	CcSEcCtD
Leflunomide—Vomiting—Saquinavir—acquired immunodeficiency syndrome	6.14e-05	0.000225	CcSEcCtD
Leflunomide—Dizziness—Lamivudine—acquired immunodeficiency syndrome	6.09e-05	0.000223	CcSEcCtD
Leflunomide—Rash—Saquinavir—acquired immunodeficiency syndrome	6.09e-05	0.000223	CcSEcCtD
Leflunomide—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	6.08e-05	0.000223	CcSEcCtD
Leflunomide—Headache—Saquinavir—acquired immunodeficiency syndrome	6.05e-05	0.000222	CcSEcCtD
Leflunomide—Nausea—Ritonavir—acquired immunodeficiency syndrome	5.96e-05	0.000218	CcSEcCtD
Leflunomide—Vomiting—Lamivudine—acquired immunodeficiency syndrome	5.86e-05	0.000215	CcSEcCtD
Leflunomide—Rash—Lamivudine—acquired immunodeficiency syndrome	5.81e-05	0.000213	CcSEcCtD
Leflunomide—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	5.8e-05	0.000213	CcSEcCtD
Leflunomide—Headache—Lamivudine—acquired immunodeficiency syndrome	5.77e-05	0.000212	CcSEcCtD
Leflunomide—Nausea—Saquinavir—acquired immunodeficiency syndrome	5.73e-05	0.00021	CcSEcCtD
Leflunomide—Nausea—Lamivudine—acquired immunodeficiency syndrome	5.47e-05	0.000201	CcSEcCtD
